![Anton Hoos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anton Hoos
Directeur/Membre du Conseil chez
Patient Focused Medicine Development
Profil
Anton Hoos currently works at Cy Biopharma AG, as Chief Executive Officer and Patient Focused Medicine Development, as Director from 2014.
Dr. Hoos also formerly worked at CSL Behring GmbH, as Vice President and Swedish Orphan Biovitrum AB, as Chief Medical Officer, Head-Medical Affairs, R&D in 2023.
Dr. Hoos received his Masters Business Admin degree from the University of Toronto and doctorate degree from Ludwig-Maximilians-Universität München.
Postes actifs de Anton Hoos
| Sociétés | Poste | Début |
|---|---|---|
Patient Focused Medicine Development | Directeur/Membre du Conseil | 01/01/2014 |
Anciens postes connus de Anton Hoos
| Sociétés | Poste | Fin |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Directeur Technique/Scientifique/R&D | 19/06/2023 |
Cy Biopharma AG
 Cy Biopharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a biotech platform generating novel psychedelic molecules for breakthrough therapeutics | Directeur Général | - |
CSL Behring GmbH
 CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Manufactures plasma protein bio therapeutics for the treatment of rare and major diseases | Corporate Officer/Principal | - |
Formation de Anton Hoos
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring GmbH
CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Manufactures plasma protein bio therapeutics for the treatment of rare and major diseases | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Patient Focused Medicine Development | |
Cy Biopharma AG
Cy Biopharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a biotech platform generating novel psychedelic molecules for breakthrough therapeutics | Commercial Services |
